Buyer profile
NHS England
Get alerts when NHS England publishes a new tender — 7-day free trial, then £4.99/month.
Total contracts
1,931
Known spend
£211bn
1802 disclosed
Average value
£117m
Per contract
Active suppliers
10
Last 5 years
Top suppliers
Last 5 years- 1
University College London Hospitals NHS Foundation Trust
19 winslatest 22 Sept 2026£5bn
- 2
ACCORD-UK LTD
£2bn
- 3
Zentiva Pharma UK Ltd
17 winslatest 27 Aug 2026£2bn
- 4
Teva UK Limited
15 winslatest 27 Aug 2026£2bn
- 5
Pfizer Ltd
14 winslatest 27 Aug 2026£3bn
- 6
Imperial College Healthcare NHS Trust
13 winslatest 28 Jan 2026£5bn
- 7
Guy's and St Thomas' NHS Foundation Trust
12 winslatest 22 Sept 2026£11bn
- 8
DR REDDY'S LABORATORIES (UK) LIMITED
£1bn
- 9
Cambridge University Hospitals NHS Foundation Trust
11 winslatest 18 May 2026£5bn
- 10
Sheffield Teaching Hospitals NHS Foundation Trust
11 winslatest 22 Sept 2026£775m
What they buy
By CPV categoryHealth & social workCPV 85
320 contracts · £42bn
Medical equipment & pharmaCPV 33
163 contracts · £25bn
Business servicesCPV 79
92 contracts · £270m
IT servicesCPV 72
58 contracts · £521m
Education & trainingCPV 80
41 contracts · £42m
SoftwareCPV 48
24 contracts · £1bn
R&D servicesCPV 73
21 contracts · £9m
Architectural & engineeringCPV 71
10 contracts · £334m
Renewal radar
Awarded contracts predicted to come up for re-tender in the next 18 months
- HSCN-AWS Connectivity Service for Spine
Predicted using median duration of UK contracts in the same CPV division (11 months from contract start date → renewal expected by May 2027).
May 2027
40% confident
- LeDeR Web Platform
Predicted using median duration of past contracts from this buyer in the same CPV division (11 months from contract start date → renewal expected by Jul 2027).
Jul 2027
60% confident
- Cyber School - Off The Shelf
Predicted using median duration of UK contracts in the same CPV division (15 months from contract start date → renewal expected by Nov 2027).
Nov 2027
40% confident
Tender activity
Notices published per month — last 24 months
All contracts (1931)
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
GPES general practice extraction service
This contract is awarded under PA23, Schedule 5 Para 7. The General Practice Extraction Service (GPES) is responsible for data extracts serving several use cases including payments
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -endoscopy training academy (ET1010)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -practice education (audiology) (ET1007)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -practice education (imaging) (ET1007)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -practice education (Q1) (ET1007)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Cancer and diagnostic -practice education (Q1) (ET1007)
The cancer and diagnostics projects covered by this business case is for the programme’s non ETAP activity. Approval is required to allow the WT&E directorate to fulfil its strateg
Diabetic eye screening programme (west midlands)
This is an intention to award notice under the competitive process. NHS England – Midlands (West) (referred to as the Commissioner) intend to award a contract to InHealth Intellige
Workflow for NHS labs delivering SCID and SMA ises (eonis-q methodology)
This is a Provider Selection Regime (PSR) Intention-to-Award Notice. This notice is subject to Regulation 10 of the Health Care Services (Provider Selection Regime) Regulations 202
Workflow for NHS labs delivering SCID and SMA ises (eonis-q methodology)
This is a Provider Selection Regime (PSR) Intention-to-Award Notice. This notice is subject to Regulation 10 of the Health Care Services (Provider Selection Regime) Regulations 202
Workflow for NHS labs delivering SCID and SMA ises (enlite methodology)
This is a Provider Selection Regime (PSR) Intention-to-Award Notice. This notice is subject to Regulation 10 of the Health Care Services (Provider Selection Regime) Regulations 202
Workflow for NHS labs delivering SCID and SMA ises (eonis-q methodology)
This is a Provider Selection Regime (PSR) Intention-to-Award Notice. This notice is subject to Regulation 10 of the Health Care Services (Provider Selection Regime) Regulations 202